Document Detail

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
MedLine Citation:
PMID:  22309669     Owner:  NLM     Status:  In-Data-Review    
Rotavirus vaccines have had a dramatic impact on morbidity and mortality from diarrhea among children in high- and middle-income countries that have introduced the vaccine into their national immunization programs. Widespread introduction of rotavirus vaccine in developing countries is imminent and their full potential in reducing the global burden from severe childhood diarrhea may soon be realized. The objectives of this paper are to describe the remaining issues and challenges in ensuring the success of the global rotavirus vaccination program and to discuss further research needed to help address them.
Jacqueline E Tate; Manish M Patel; Margaret M Cortese; Benjamin A Lopman; Jon R Gentsch; Jessica Fleming; A Duncan Steele; Umesh D Parashar
Related Documents :
22699439 - News.
22825289 - Rabies pretravel vaccination.
22579479 - Polymorphism of rotavirus genotype g1 in brazil: in silico analysis of variant strains ...
22471199 - Gaps in the knowledge about advancements in rabies vaccines among the undergraduate med...
22377789 - Deficient long-term response to pandemic vaccine results in an insufficient antibody re...
22890129 - Evaluation of an in vitro assay system as a potential alternative to current histamine ...
12826449 - Bacterial meningitis in children.
8896049 - Ethnicity and proficiency in english as factors affecting community cardiopulmonary res...
23283639 - Characterization of novel multiantigenic vaccine candidates with pan-hla coverage again...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of vaccines     Volume:  11     ISSN:  1744-8395     ISO Abbreviation:  Expert Rev Vaccines     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101155475     Medline TA:  Expert Rev Vaccines     Country:  England    
Other Details:
Languages:  eng     Pagination:  211-20     Citation Subset:  IM    
Centers for Disease Control and Prevention, 1600 Clifton Road, NE MS-A34, Atlanta, GA 30333, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Technologies for enhanced efficacy of DNA vaccines.
Next Document:  Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.